BEST1 and Best vitelliform macular dystrophy: By demonstrating the efficacy of 4PBA in restoring expression and function of mutant bestrophin 1 proteins associated with either BVMD or ARB, we have shown that autosomal dominant and recessive disorders may be amenable to treatment with the same therapeutic molecule.